Evidence map›Paper›PMID 34040495›Full record

ArticleHealth services & outcomes research methodology2021

Veridical Causal Inference using Propensity Score Methods for Comparative Effectiveness Research with Medical Claims.

Ryan D Ross, Xu Shi, Megan E V Caram, Pheobe A Tsao, Paul Lin, Amy Bohnert, Min Zhang, Bhramar Mukherjee

Open access · greenAbstract read
In one paragraph

Article in Health services & outcomes research methodology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ryan D RossDepartment of Biostatistics, School of Public Health, University of Michigan.
Xu ShiDepartment of Biostatistics, School of Public Health, University of Michigan.
Megan E V CaramDepartment of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School.
Pheobe A TsaoDepartment of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School.
Paul LinInstitute for Health Policy and Innovation, University of Michigan Medical School.
Amy BohnertVA Health Services Research & Development, Center for Clinical Management and Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.
Min ZhangDepartment of Biostatistics, School of Public Health, University of Michigan.
Bhramar MukherjeeDepartment of Biostatistics, School of Public Health, University of Michigan.
University of Michigan · USHealth Services Research & Development · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
NCI NIH HHS P30 CA046592
6 · The paper itself

Abstract

Medical insurance claims are becoming increasingly common data sources to answer a variety of questions in biomedical research. Although comprehensive in terms of longitudinal characterization of disease development and progression for a potentially large number of patients, population-based inference using these datasets require thoughtful modifications to sample selection and analytic strategies relative to other types of studies. Along with complex selection bias and missing data issues, claims-based studies are purely observational, which limits effective understanding and characterization of the treatment differences between groups being compared. All these issues contribute to a crisis in reproducibility and replication of comparative findings using medical claims. This paper offers practical guidance to the analytical process, demonstrates methods for estimating causal treatment effects with propensity score methods for several types of outcomes common to such studies, such as binary, count, time to event and longitudinally-varying measures, and also aims to increase transparency and reproducibility of reporting of results from these investigations. We provide an online version of the paper with readily implementable code for the entire analysis pipeline to serve as a guided tutorial for practitioners. The online version can be accessed at https://rydaro.github.io/. The analytic pipeline is illustrated using a sub-cohort of patients with advanced prostate cancer from the large Clinformatics TM Data Mart Database (OptumInsight, Eden Prairie, Minnesota), consisting of 73 million distinct private payer insurees from 2001-2016.

Indexed as

average treatment effectcovariate adjustmenthormone therapyinsurance claimsmatchingprostate cancerreproducibilitysensitivity analysisveridical data science

Identifiers

PMID34040495
PMCPMC8142944
OpenAlexW3094603967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.